Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-24-038658

Chief Financial Officer sold 348 shares at $7.70 ($2,680)

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-27 Sale : show line 1 in the form −348 $7.70 $2,680 341,498 D
Open-market sales · 348 sh · avg $7.70 · $2,680
Loading xslF345X05/ownership.xml…